Compare Stocks

Baird Medical Investment NASDAQ:BDMDW

Envoy Medical NASDAQ:COCHW

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

DIH Holding US NASDAQ:DHAIW

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider in the rehabilitation industry. The company's upper extremity product categories include ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; and Armeo Senso, a sensor-based solution for arm function recovery. It also provides lower extremity product categories comprising Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, an Computer Assisted Rehabilitation Environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, the company offers M-Gait, a modular treadmill system; SafeGait, a balance and mobility trainer; and RYSEN, an 3D bodyweight supporter, as well as software products consist of D-Flow and HocoNet. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

Alpha Tau Medical NASDAQ:DRTSW

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.